Infectious disease medical coding draws from two primary ICD-10-CM chapters and intersects with coding rules across E/M, infusion, laboratory, and surgical procedure categories. The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), maintained jointly by the Centers for Disease Control and Prevention (CDC) and CMS, organizes infectious disease diagnoses primarily in Chapter 1 (Certain Infectious and Parasitic Diseases, A00-B99) and Chapter 10 (Diseases of the Respiratory System, J00-J99) for respiratory infections. Accurate ICD-10-CM selection requires understanding the principal diagnosis sequencing rules that apply to conditions such as sepsis, HIV disease, and healthcare-associated infections, where the sequencing order affects both reimbursement and compliance with Official Coding Guidelines published by the American Health Information Management Association (AHIMA).
Primary ICD-10-CM Code Ranges for Infectious Disease
The core infectious disease ICD-10-CM ranges span Chapters 1 and 1A of the code set. Chapter 1 (A00-B99) covers intestinal infectious diseases (A00-A09), tuberculosis (A15-A19), sexually transmitted infections (A50-A64), viral infections including HIV (B20), mycoses (B35-B49), viral hepatitis (B15-B19), and protozoal diseases (B50-B64). Chapter 10 respiratory infections (J00-J22) frequently appear in infectious disease practice for community-acquired pneumonia (J18.9), influenza (J09-J11), and acute bronchitis (J20). Long COVID coding falls under U09.9 (post-COVID-19 condition, unspecified), a code from the COVID-19 chapter added to ICD-10-CM effective October 2021.
HIV and AIDS Coding Rules
HIV disease coding follows specific Official Coding Guidelines. ICD-10-CM code B20 (Human immunodeficiency virus disease) is the principal diagnosis only when the patient is symptomatic: presenting with an AIDS-defining condition or a complication directly attributable to HIV. When an HIV-positive patient presents for an unrelated condition (e.g., a fracture or hypertension), the unrelated condition is the principal diagnosis and B20 is coded additionally. When the patient is HIV-positive but asymptomatic (no AIDS-defining condition, no active HIV-related illness), code Z21 (asymptomatic human immunodeficiency virus infection status) applies, not B20. Using B20 for an asymptomatic HIV-positive patient constitutes a coding error that can trigger a payer audit.
Sepsis Coding and Principal Diagnosis Sequencing
Sepsis coding is one of the most frequently audited areas in infectious disease. Per Official ICD-10-CM Guidelines, sepsis (A41.9 for unspecified organism) is the principal diagnosis when it is the condition chiefly responsible for the admission. The causative organism is coded additionally when identified: A41.01 for MRSA sepsis, A41.51 for Staphylococcus aureus sepsis. Severe sepsis (a subset of sepsis with organ dysfunction) adds code R65.20 (severe sepsis without septic shock) or R65.21 (with septic shock). The organ dysfunction(s) are coded additionally (e.g., N17.9 for acute kidney failure). Sepsis due to a postprocedural infection sequences differently: the postprocedural complication code (T81.40XA) precedes the sepsis code.
Key Modifiers for Infectious Disease Billing
Five modifiers are critical in infectious disease billing. Modifier 25 (significant, separately identifiable E/M on same day as procedure) applies when the physician bills a visit code alongside an infusion code. Modifier 59 (distinct procedural service) differentiates two procedures that would otherwise be bundled by CCI edits, though for infusion billing, modifier 91 (repeat clinical diagnostic lab test) is more accurate than modifier 59 when re-running the same lab test on the same date. Modifier 51 (multiple procedures) reduces the payment on secondary procedures billed with a primary procedure. Modifier GT (via interactive audio and video telecommunications) applies to telehealth infectious disease visits. Modifier QW (CLIA-waived test) applies to point-of-care rapid tests performed under a CLIA waiver certificate.
Common Infectious Disease Coding Errors and Audit Risks
Four coding errors drive the majority of infectious disease audits. First, coding B20 for asymptomatic HIV-positive patients instead of Z21. Second, sequencing postprocedural sepsis with the sepsis code first instead of the complication code. Third, billing laboratory NAAT codes (87491, 87798) without a CLIA certificate or the technical component. Fourth, billing CPT 96365 twice for the same drug instead of the correct 96365 plus 96366 sequence. CMS Recovery Audit Contractors (RACs) and commercial payer Special Investigations Units (SIUs) actively review infectious disease infusion claims for these patterns. A quarterly internal coding audit against these four error categories reduces audit exposure and prevents overpayment demand letters.